We are live on ! Find out more
RL

Ruffer LLP Portfolio holdings

AUM $2.83B
1-Year Est. Return 30.34%
This Fund
S&P 500
This Quarter Est. Return
-8.55%
1 Year Est. Return
+30.34%
3 Year Est. Return
+98.01%
5 Year Est. Return
+139.76%
10 Year Est. Return
+587.97%
AUM
$3.16B
AUM Growth
-$410M
Cap. Flow
-$33.1M
Cap. Flow %
-1.05%
Top 10 Hldgs %
64.23%
Holding
98
New
9
Increased
25
Reduced
29
Closed
8

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$115M
2
CI icon
Cigna
CI
+$76.9M
3
WPM icon
Wheaton Precious Metals
WPM
+$42.8M
4
CAR icon
Avis
CAR
+$40.3M
5
KGC icon
Kinross Gold
KGC
+$36.4M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$183M
2
CNC icon
Centene
CNC
+$137M
3
AXP icon
American Express
AXP
+$42.7M
4
NTR icon
Nutrien
NTR
+$38.8M
5
BMY icon
Bristol-Myers Squibb
BMY
+$19.8M

Sector Composition

Rank Sector Weight
1 Healthcare 31.32%
2 Materials 22.81%
3 Financials 15.4%
4 Consumer Staples 10.93%
5 Energy 10%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARCO icon
76
Arcos Dorados Holdings
ARCO
$1.72B
$776K 0.02%
152,142
-3
-0% -$17
NEE icon
77
NextEra Energy
NEE
$181B
$765K 0.02%
9,700
– –
BABA icon
78
Alibaba
BABA
$293B
$760K 0.02%
5,295
-46,497
-90% -$8.46M
HUM icon
79
Humana
HUM
$43.7B
$701K 0.02%
1,799
-207
-10% -$87.9K
AAPL icon
80
Apple
AAPL
$4.54T
$678K 0.02%
4,776
– –
GASS icon
81
StealthGas
GASS
$332M
$546K 0.02%
200,000
– –
GLD icon
82
SPDR Gold Trust
GLD
$131B
$526K 0.02%
3,211
+78
+2% +$13.1K
VIPS icon
83
Vipshop
VIPS
$7.37B
$491K 0.02%
45,191
-357,309
-89% -$5.62M
HMY icon
84
Harmony Gold Mining
HMY
$9.84B
$475K 0.02%
149,785
– –
GDX icon
85
VanEck Gold Miners ETF
GDX
$22.7B
$468K 0.01%
16,025
-36
-0.2% -$1.17K
MRSH
86
Marsh
MRSH
$90.5B
$445K 0.01%
2,900
-500
-15% -$75.6K
CHKP icon
87
Check Point Software Technologies
CHKP
$13B
$319K 0.01%
2,808
-41
-1% -$4.99K
AFL icon
88
Aflac
AFL
$64.9B
$252K 0.01%
4,778
-62,569
-93% -$3.42M
SPOT icon
89
Spotify
SPOT
$103B
$216K 0.01%
947
-13,165
-93% -$3.1M
PSHG icon
90
Performance Shipping
PSHG
$21.6M
$198K 0.01%
2,333
– –
ACGL icon
91
Arch Capital
ACGL
$34.3B
– –
-6,000
Closed -$234K
APTV icon
92
Aptiv
APTV
$12B
– –
-1,305
Closed -$205K
DESP
93
DELISTED
Despegar.com
DESP
– –
-450,000
Closed -$5.95M
KHC icon
94
Kraft Heinz
KHC
$30.7B
– –
-35,000
Closed -$1.43M
NXPI icon
95
NXP Semiconductors
NXPI
$57.8B
– –
-985
Closed -$203K
VZ icon
96
Verizon
VZ
$195B
– –
-113,824
Closed -$6.38M
KOR
97
DELISTED
Corvus Gold Inc. Common Shares
KOR
– –
-1,662,119
Closed -$4.63M
ALXN
98
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-998,268
Closed -$183M
1 2 3
4

Similar funds

GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
AIP
Atlas Infrastructure Partners London, United Kingdom $2.84B AUM 4.75% 1-Year Est. Return
AF
Aviso Financial Toronto, Ontario, Canada $2.82B AUM 24.96% 1-Year Est. Return
SAI
Systematic Alpha Investments Princeton, New Jersey $2.84B AUM 27.03% 1-Year Est. Return
MWM
Meridian Wealth Management Lexington, Kentucky $2.85B AUM 31.23% 1-Year Est. Return
MSDF
Michael & Susan Dell Foundation New York $2.85B AUM 26.28% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return

Ruffer LLP's Q3 2021 Portfolio in Review

As of Q3 2021, Ruffer LLP held 98 positions worth $3.16B, down 11% from $3.57B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Ruffer LLP's Q3 2021 filing shows 9 new, 25 increased, 29 reduced and 8 closed positions. Its largest new stake was AstraZeneca: 985,898 shares worth $117M. The largest sale was Alexion Pharmaceuticals, an estimated $183M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 35% a quarter earlier, followed by Materials and Financials.

  • Ruffer LLP's largest Q3 2021 buy was AstraZeneca: 985,898 shares worth $117M.
  • Ruffer LLP added most to Cigna in Q3 2021, an estimated $76.9M increase.
  • Ruffer LLP's biggest Q3 2021 reduction was Centene, cutting an estimated $137M.
  • Ruffer LLP fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $183M.
  • Ruffer LLP's ten largest holdings make up 64% of its $3.16B portfolio in Q3 2021.
  • Ruffer LLP opened 9 new positions and closed 8 in Q3 2021.
  • Ruffer LLP's portfolio value fell 11% quarter-over-quarter to $3.16B.

Based on Ruffer LLP's 13F filing for Q3 2021, filed 10 Nov 2021.